Author | Emmanuel Antonarakis, MD

Articles

Synthetic Lethality of PARP Inhibitors in Prostate Cancer

May 03, 2018

In this podcast, Dr. Emmanuel Antonarakis discusses his novel clinical trial evaluating PARP inhibitors in high-risk and biochemically recurrent prostate cancer.